Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ASH 2022
Pharma
ASH: Amgen's Blincyto looks to establish new leukemia standard
Blincyto helped patients with newly diagnosed B lineage ALL who had a good prognosis after an initial round of chemotherapy live longer.
Angus Liu
Dec 13, 2022 10:00am
Abecma's 3rd-line myeloma data not selected by ASH22
Dec 12, 2022 5:08pm
CSL's hemophilia B gene therapy works well through 24 months
Dec 12, 2022 2:14pm
ASH: Roche braces for lymphoma bispecific war
Dec 11, 2022 6:30pm
ASH: Bristol bolsters Breyanzi's case in earlier lymphoma
Dec 11, 2022 5:30pm
ASH: Bluebird's lovo-cel on track for submission in Q1 of 2023
Dec 10, 2022 11:30am
